Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 2 | 3003831 | — |
The patient took two doses of Vivotif on schedule and forgot next two doses due to busy schedule; Case reference number US-BN-2024-000014 is a spontaneous case report initially received from other health care professional via Med Communication (reference number: USBAV24-0021) on 04-Jan-2024 and concerns a 34-year-old female patient. The patient's relevant medical history and concomitant medications were not provided. On unspecified date, the patient was vaccinated with the first dose of Vivotif (batch number: 3003831), at unknown dose and route of administration for unknown indication. On unspecified date, an unknown amount of time after the first dose of Vivotif, the patient was vaccinated with second dose of Vivotif vaccine (batch number: 3003831), at unknown dose and route of administration. As reported, the patient received two doses of Vivotif on schedule and forgot next two doses of Vivotif due to busy schedule (explicitly coded as 'incomplete course of vaccination'). At the time of initial report, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. No further information provided.; Reporter's Comments: A 34-year-old female patient received two doses of Vivotif on schedule and forgot next two doses of Vivotif due to busy schedule, which is considered as incomplete course of vaccination. No associated adverse events were reported. Incomplete course of vaccination is listed per company convention. The patient's relevant medical history and concomitant medications were not provided. Incomplete course of vaccination is not related to Vivotif, but to a human factor. The case is non-serious.; Sender's Comments: A 34-year-old female patient received two doses of Vivotif on schedule and forgot next two doses of Vivotif due to busy schedule, which is considered as incomplete course of vaccination. No associated adverse events were reported. Incomplete course of vaccination is listed per company convention. The patient's relevant medical history and concomitant medications were not provided. Incomplete course of vaccination is not related to Vivotif, but to a human factor. The case is non-serious.
Comments: None